• 学术搜索
  • 科研智能体
    • Research Labs
    • AI 阅读
    • AI 文库
    • 深度研究
    • 学者亮点
  • 学术资源
    • AI2000
    • 期刊/会议
    • 学者库
    • 学术API
      MCP&Skill
    • 溯源树
    • 数据集
  • 知识沉淀
    • 学术空间
订阅小程序
旧版功能
aminer vip
开通会员低至0.73元/天
一次搞定AI科研
立即登录
  • English
  • 联系方式
    International Journal of Drug Policy

    International Journal of Drug Policy

    JournalISSN 0955-3959eISSN 1873-4758中科院 医学 2区

    年发文量

    研究主题

    论文(4703)

    排序
    1NewAssociations Between Receipt of Prescribed Safer Supply and Health and Social Outcomes in the Short Term: a Prospective Cohort Study
    Karen Urbanoski,Thea van Roode, Omid Gheysar Gharamaleki, Katherine Hogan,Brittany Barker,Amanda Slaunwhite,Bohdan Nosyk,Bernadette Pauly

    Background British Columbia, Canada introduced clinical guidance to support the prescription of pharmaceutical alternatives to the toxic unregulated drug supply in 2020, also known as prescribed safer supply (PSS). This provincial prospective cohort study evaluates the associations between PSS receipt and self-reported health and social outcomes. Methods Data were collected in 2020–2021 using a longitudinal survey of people who had received a prescription or were seeking one (n = 161), with up to 5 time points per participant over 3 months. Generalised estimating equations were used to assess the effects of time-varying prescription exposure (yes/no) on outcomes over the follow-up period, controlling for encounters with police and bylaw officers, service use, social support, and sociodemographic characteristics. Outcomes included quality of life (EuroQOL-5D), depression (PHQ-2), anxiety (GAD-2), frequency of unregulated substance use, COVID-19 protective behaviours, and reliance on criminalized income sources. Results PSS receipt was negatively associated with depression (adj. b = -0.44, 95% CI= -0.81, -0.08) and frequency of unregulated substance use (adj. b = -0.23, 95% CI = -0.45, -0.014) over the study period. Independent of PSS receipt, there was no evidence of change in outcomes over the 12 weeks, except for a small increase in COVID-19 protective behaviours over time (adj. b = 0.004, 95% CI = 0.001, 0.007). Discussion Findings signal the potential promise of PSS, along with the need for improvement of existing service models. Further research is needed to inform the development of models that combine prescriptions with comprehensive services and supports to maximize positive outcomes.

    2027
    引用
    AI阅读
    加入学术空间
    2NewHow Do Diverse Positive and Negative Bodily Trajectories Shape Young People’s Substance Use Practices over Time? Mapping and Following Lines of Becoming and Their Entanglements
    Jukka Törrönen,Josefin Månsson,Filip Roumeliotis,Eva Samuelsson

    Background The article takes a critical view of ‘a motivation model for alcohol use’ and its findings, treating young people’s substance use as a dynamic process shaped by diverse, heterogeneous forces. Methods The data consist of qualitative longitudinal interviews with young people describing their substance use practices. These practices are approached as assemblages that produce ongoing bodily lines of becoming, which can either enhance or diminish their capacities for well-being. The study identifies the diverse bodily lines of becoming produced by participants’ substance-use assemblages and analyzes how these lines, when they intersect, shape participants’ knowledge, habits, and identities related to substance use. Results The analysis shows that substance use produces multiple bodily lines, such as becoming a group; becoming strong, brave, and true to oneself; becoming happier; becoming functional, focused, and present; becoming insecure about appearance; becoming unwell, anxious, and sick; and becoming ashamed. Even if one bodily line dominates as a theme in participants’ substance use assemblages, such as becoming powerful, extroverted, or functional, the other bodily lines still exert a strong influence on how substance use practices develop, what forms they take, and what kinds of futures they open up. Conclusions Substance use is not predetermined by motives. Instead, it generates multiple bodily lines that interact in tense ways. In this landscape, the person using substances must constantly adapt to meet the challenges and demands that these lines impose on one another.

    2026
    引用
    AI阅读
    加入学术空间
    3NewCorrigendum to “social Media Nicotine Markets: Criminogenic Affordances and Market Displacements” [international Journal of Drug Policy, Volume 145, 104943]
    K. Aagesen, A. Moretti, J. Demant
    2026
    引用
    AI阅读
    加入学术空间
    4NewWalking Alongside Aboriginal Youth on Dunghutti Country. Perspectives on Alcohol and Other Drug Education, Care and Treatment
    Teneale Lavender, Bert Gray, Simone Smith
    2026
    引用
    AI阅读
    加入学术空间
    5NewOpioid Prescribing Policies and Opioid Misuse: Identifying Effects with and Without Cannabis Supply
    Magdalena Cerdá,Emilie Bruzelius,Katherine Wheeler-Martin,Christine M. Mauro,Kara E. Rudolph,Corey S. Davis,Silvia S. Martins

    OBJECTIVES We examined the effects of state must-query prescription drug monitoring program (MQ-PDMP) and opioid prescribing limit (OPL) laws on past-year opioid misuse and opioid use disorder (OUD), in the presence and absence of legal cannabis. METHODS We used the 2015-2019 US National Survey on Drug Use and Health. We obtained policy measures from the Prescription Drug Abuse Policy System, prior literature, and statutory data. We estimated policy effects in states with and without a legal cannabis supply using two-way fixed effects models. RESULTS Relative to states without MQ-PDMP, MQ-PDMP adoption with no legal cannabis supply was associated with (non-significant) higher odds of past-year opioid misuse (AOR: 1.30; 95% CI: 1.00-1.68) and (significant) higher odds of OUD (AOR: 1.82; 95% CI: 1.09-3.03). In states with legal cannabis, MQ-PDMP adoption was associated with lower (non-significant) odds of past-year opioid misuse (AOR: 0.87; 95% CI: 0.74-1.04) and lower (non-significant) odds of OUD (AOR: 0.80; 95% CI: 0.56-1.13) compared to states without MQ-PDMP. Similar results were found for OPL and opioid misuse. OPL with legal cannabis was associated with lower (significant) odds of OUD (AOR: 0.69; 95% CI: 0.48-0.99), relative to states without an OPL. PUBLIC HEALTH IMPLICATIONS While the estimates suggest increases in opioid misuse and OUD associated with opioid prescription policies in states without legal cannabis supply, and the opposite in states with cannabis supply, imprecise estimates make it difficult to determine whether the observed patterns reflect true effects or limited precision in the policy contrasts.

    2026
    引用
    AI阅读
    加入学术空间
    立即登录,查看全部 4703 篇论文

    高被引作者

    作者引用发文
    Thomas Kerr432094
    Tim Rhodes431157
    Evan Wood314258
    Jason Grebely247888
    Louisa Jane Degenhardt220859
    Daniel H Ciccarone214117
    Carla Treloar210484
    Steffanie Strathdee199748
    Will Small184228
    Magdalena Harris181828

    高产作者

    作者引用发文
    Thomas Kerr432094
    Jason Grebely247888
    Carla Treloar210484
    Louisa Jane Degenhardt220859
    Evan Wood314258
    Tim Rhodes431157
    Gregory John Dore181855
    Matthew Hickman149454
    Alison Ritter128151
    Steffanie Strathdee199748

    相关期刊

    Drug And Alcohol Review
    Harm reduction journal
    Drugs (Abingdon, England)
    Drug and Alcohol Dependence
    Addiction
    Journal of Substance Abuse Treatment
    Substance Abuse: Treatment, Prevention, and Policy
    Contemporary Drug Problems
    Journal of Drug Issues
    Drugs-education Prevention and Policy